Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:723-728

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egan, B. M.
Right arrow Articles by Goodfriend, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egan, B. M.
Right arrow Articles by Goodfriend, T. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
Medline Plus Health Information
*High Blood Pressure
*Obesity

(Hypertension. 1996;27:723-728.)
© 1996 American Heart Association, Inc.


Articles

Obesity Hypertension Is Related More to Insulin's Fatty Acid Than Glucose Action

Brent M. Egan; Magda M.I. Hennes; Konrad T. Stepniakowski; Irene M. O'Shaughnessy; Ahmed H. Kissebah; Theodore L. Goodfriend

From the Division of Clinical Pharmacology, Departments of Pharmacology and Medicine, Medical University of South Carolina, Charleston (B.M.E., K.T.S.); the Division of Endocrinology, Metabolism, and Clinical Nutrition, Department of Medicine, Medical College of Wisconsin, Milwaukee (M.M.I.H., I.M.O., A.H.K.); and the Departments of Medicine and Pharmacology, University of Wisconsin and William S. Middleton Veterans Memorial Hospital, Madison (T.L.G.).

Abstract Although resistance to insulin-mediated glucose disposal has emerged as a link between abdominal obesity and hypertension, abnormalities of nonesterified fatty acid metabolism may play a greater role. Analyses were performed on existing data from 17 abdominally obese subjects (11 hypertensive, 6 normotensive) to determine whether fatty acid concentration and turnover were related to blood pressure independently of hyperinsulinemia and resistance to insulin-mediated glucose disposal. Glucose utilization, fatty acid concentration, and fatty acid turnover were obtained fasting and during euglycemic hyperinsulinemia at 10 and 40 mU·m-2·min-1. Analyses were also performed on another group of 30 subjects with a wide range of risk factors who had blood pressure data as well as glucose and fatty acid measurements during an insulin tolerance test.

Fatty acid concentration and turnover were markedly more resistant to suppression by insulin in obese hypertensive than in lean or obese normotensive individuals. In the 17 obese subjects, blood pressure measured at screening, in the laboratory, and over a period of 24 hours correlated significantly with fatty acid concentration and turnover but not with glucose disposal measured during the hyperinsulinemic clamp. These correlations remained significant after fasting insulin, the insulin area under the curve during an oral glucose tolerance test, and glucose disposal during the clamp were controlled for. In the second group of subjects, plasma fatty acids 15 minutes after intravenous insulin also correlated with blood pressure. These correlations remained significant after insulin and an index of sensitivity to insulin-mediated glucose disposal were statistically controlled for. The data indicate that blood pressure is related to the effects of insulin on fatty acid metabolism. The findings raise the possibility that resistance of hormone-sensitive lipase to insulin participates in elevating the blood pressure of abdominally obese hypertensive subjects by increasing fatty acid concentration and turnover.


Key Words: obesity • insulin • glucose • fatty acids, nonesterified




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
G. E. Umpierrez, D. Smiley, G. Robalino, L. Peng, A. E. Kitabchi, B. Khan, A. Le, A. Quyyumi, V. Brown, and L. S. Phillips
Intravenous Intralipid-Induced Blood Pressure Elevation and Endothelial Dysfunction in Obese African-Americans with Type 2 Diabetes
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 609 - 614.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Nielsen, J. R. Halliwill, M. J. Joyner, and M. D. Jensen
Vascular Response to Angiotensin II in Upper Body Obesity
Hypertension, October 1, 2004; 44(4): 435 - 441.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Haastrup, C. A. Gadegbeku, D. Zhang, Y. V. Mukhin, E. L. Greene, A. A. Jaffa, and B. M. Egan
Lipids Stimulate the Production of 6-keto-prostaglandin F1{alpha} in Human Dorsal Hand Veins
Hypertension, October 1, 2001; 38(4): 858 - 863.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. P. Stojiljkovic, D. Zhang, H. F. Lopes, C. G. Lee, T. L. Goodfriend, and B. M. Egan
Hemodynamic effects of lipids in humans
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1674 - R1679.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Carlsson, Y. Wessman, P. Almgren, and L. Groop
High Levels of Nonesterified Fatty Acids Are Associated With Increased Familial Risk of Cardiovascular Disease
Arterioscler Thromb Vasc Biol, June 1, 2000; 20(6): 1588 - 1594.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. T. Haastrup, K. T. Stepniakowski, T. L. Goodfriend, and B. M. Egan
Intralipid Enhances {alpha}1-Adrenergic Receptor–Mediated Pressor Sensitivity
Hypertension, October 1, 1998; 32(4): 693 - 698.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. T. Stepniakowski, G. Lu, G. D. Miller, and B. M. Egan
Fatty Acids, Not Insulin, Modulate {alpha}1-Adrenergic Reactivity in Dorsal Hand Veins
Hypertension, November 1, 1997; 30(5): 1150 - 1155.
[Abstract] [Full Text]